• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带新型CECR1突变的腺苷脱氨酶2缺乏症两兄弟中的具有I型干扰素特征的自身免疫表型。

Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.

作者信息

Skrabl-Baumgartner Andrea, Plecko Barbara, Schmidt Wolfgang M, König Nadja, Hershfield Michael, Gruber-Sedlmayr Ursula, Lee-Kirsch Min Ae

机构信息

Department of Pediatrics and Adolescent Medicine, Medical University Graz, Auenbruggerplatz 34/2, 8036, Graz, Austria.

Division of Child Neurology, University Children's Hospital, University of Zurich, Zurich, Switzerland.

出版信息

Pediatr Rheumatol Online J. 2017 Aug 22;15(1):67. doi: 10.1186/s12969-017-0193-x.

DOI:10.1186/s12969-017-0193-x
PMID:28830446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5568374/
Abstract

BACKGROUND

Loss-of-function CECR1 mutations cause polyarteritis nodosa (PAN) with childhood onset, an autoinflammatory disorder without significant signs of autoimmunity. Herein we describe the unusual presentation of an autoimmune phenotype with constitutive type I interferon activation in siblings with adenosine deaminase 2 (ADA2) deficiency.

CASE PRESENTATION

We describe two siblings with early-onset recurrent strokes, arthritis, oral ulcers, discoid rash, peripheral vascular occlusive disease and high antinuclear antibody titers. Assessment of interferon signatures in blood revealed constitutive type I interferon activation. Aicardi-Goutières syndrome (AGS) was suspected, but no mutation in the known AGS genes were detected. Whole exome sequencing identified compound heterozygosity for a known and a novel mutation in the CECR1 gene. Functional consequences of the mutations were demonstrated by marked reduction in ADA2 catalytic activity.

CONCLUSIONS

Our findings demonstrate that ADA2 deficiency can cause an unusual autoimmune phenotype extending the phenotypic spectrum of PAN. Constitutive interferon I activation in patient blood suggests a possible role of type I interferon in disease pathogenesis which may have therapeutic implications.

摘要

背景

功能丧失性CECR1突变导致儿童期发病的结节性多动脉炎(PAN),这是一种无明显自身免疫迹象的自身炎症性疾病。在此,我们描述了腺苷脱氨酶2(ADA2)缺乏症患者同胞中具有组成型I型干扰素激活的自身免疫表型的异常表现。

病例报告

我们描述了两名患有早发性复发性中风、关节炎、口腔溃疡、盘状皮疹、外周血管闭塞性疾病和高抗核抗体滴度的同胞。对血液中干扰素特征的评估显示存在组成型I型干扰素激活。怀疑为Aicardi-Goutières综合征(AGS),但未检测到已知AGS基因的突变。全外显子测序确定了CECR1基因中一个已知突变和一个新突变的复合杂合性。通过ADA2催化活性的显著降低证明了这些突变的功能后果。

结论

我们的研究结果表明,ADA2缺乏可导致异常的自身免疫表型,扩展了PAN的表型谱。患者血液中的组成型I型干扰素激活提示I型干扰素在疾病发病机制中可能起作用,这可能具有治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5568374/80f39bc20dd6/12969_2017_193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5568374/72ae7121e348/12969_2017_193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5568374/80f39bc20dd6/12969_2017_193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5568374/72ae7121e348/12969_2017_193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f72/5568374/80f39bc20dd6/12969_2017_193_Fig2_HTML.jpg

相似文献

1
Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.携带新型CECR1突变的腺苷脱氨酶2缺乏症两兄弟中的具有I型干扰素特征的自身免疫表型。
Pediatr Rheumatol Online J. 2017 Aug 22;15(1):67. doi: 10.1186/s12969-017-0193-x.
2
Mutations in CECR1 associated with a neutrophil signature in peripheral blood.与外周血中性粒细胞特征相关的CECR1突变。
Pediatr Rheumatol Online J. 2014 Sep 24;12:44. doi: 10.1186/1546-0096-12-44. eCollection 2014.
3
Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.腺苷脱氨酶 2 缺乏症:15 例表型和基因型描述。
Arthritis Rheumatol. 2016 Sep;68(9):2314-22. doi: 10.1002/art.39699.
4
Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.由于相同的纯合R169Q突变导致的ADA2缺乏症患者的表型变异性。
Rheumatology (Oxford). 2016 May;55(5):902-10. doi: 10.1093/rheumatology/kev439. Epub 2016 Feb 10.
5
Early-onset stroke and vasculopathy associated with mutations in ADA2.早发性卒中和与 ADA2 突变相关的血管病变。
N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.
6
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.ADA2 缺陷(DADA2)作为早发性多动脉炎和卒中的一个未被识别病因:一项多中心全国性研究。
Ann Rheum Dis. 2017 Oct;76(10):1648-1656. doi: 10.1136/annrheumdis-2016-210802. Epub 2017 May 18.
7
Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.ADA2 缺陷的可变临床表型与疾病活动的干扰素特征的关系。
J Rheumatol. 2019 May;46(5):523-526. doi: 10.3899/jrheum.180045. Epub 2019 Jan 15.
8
A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.一种具有多种表型的单基因疾病:腺苷脱氨酶 2 缺乏症。
J Rheumatol. 2020 Jan;47(1):117-125. doi: 10.3899/jrheum.181384. Epub 2019 May 1.
9
Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2).腺苷脱氨酶 2 缺乏症(DADA2)酶活性测定在诊断中的重要性。
Med Clin (Barc). 2022 Sep 23;159(6):283-286. doi: 10.1016/j.medcli.2021.12.020. Epub 2022 Feb 28.
10
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.腺苷脱氨酶 2 缺乏症(DADA2):一种结节性多动脉炎的遗传性病因,也是其他系统性风湿性疾病的类似病症。
Curr Rheumatol Rep. 2017 Oct 5;19(11):70. doi: 10.1007/s11926-017-0699-8.

引用本文的文献

1
Human ADA2 Deficiency: Ten Years Later.人类 ADA2 缺乏症:十年后。
Curr Allergy Asthma Rep. 2024 Sep;24(9):477-484. doi: 10.1007/s11882-024-01163-9. Epub 2024 Jul 6.
2
Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.腺苷脱氨酶 2 缺乏伴 EBV 感染失控导致 EBV 相关弥漫性大 B 细胞淋巴瘤的发生。
J Clin Immunol. 2024 May 17;44(5):118. doi: 10.1007/s10875-024-01712-x.
3
Kidney Involvement in Autoinflammatory Diseases.自身炎症性疾病中的肾脏受累

本文引用的文献

1
The Type I Interferonopathies.Ⅰ型干扰素病。
Annu Rev Med. 2017 Jan 14;68:297-315. doi: 10.1146/annurev-med-050715-104506. Epub 2016 Nov 2.
2
Monogenic polyarteritis: the lesson of ADA2 deficiency.单基因性多动脉炎:ADA2缺乏症的教训。
Pediatr Rheumatol Online J. 2016 Sep 8;14(1):51. doi: 10.1186/s12969-016-0111-7.
3
Familial chilblain lupus due to a gain-of-function mutation in STING.家族性冻疮样狼疮继发于 STING 基因功能获得性突变。
Kidney Dis (Basel). 2023 Feb 28;9(3):157-172. doi: 10.1159/000529917. eCollection 2023 May.
4
A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran.伊朗十加一腺苷脱氨酶 2 (DADA2) 缺乏症患者病例系列。
Pediatr Rheumatol Online J. 2023 Jun 13;21(1):55. doi: 10.1186/s12969-023-00838-3.
5
A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review.广泛表型的脱氨酶 2 缺乏症(DADA2):系统文献回顾。
Orphanet J Rare Dis. 2023 May 13;18(1):117. doi: 10.1186/s13023-023-02721-6.
6
A Cohort Study on Deficiency of ADA2 from China.中国 ADA2 缺乏症的队列研究。
J Clin Immunol. 2023 May;43(4):835-845. doi: 10.1007/s10875-023-01432-8. Epub 2023 Feb 18.
7
Pathogenic variant c.1052T>A (p.Leu351Gln) in adenosine deaminase 2 impairs secretion and elevates type I IFN responsive gene expression.腺苷脱氨酶 2 中的致病变体 c.1052T>A(p.Leu351Gln)可损害其分泌功能并升高 I 型干扰素应答基因的表达。
Front Immunol. 2022 Sep 30;13:995191. doi: 10.3389/fimmu.2022.995191. eCollection 2022.
8
Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency.病例报告:以病毒感染易感性和继发性噬血细胞性淋巴组织细胞增生症为表现的腺苷脱氨酶 2 缺乏症对静脉注射免疫球蛋白有反应。
Front Immunol. 2022 Sep 9;13:937108. doi: 10.3389/fimmu.2022.937108. eCollection 2022.
9
Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.多基因自身免疫性疾病风险等位基因在小鼠和人类的共享分子网络中协同作用,影响 B 细胞耐受。
Front Immunol. 2022 Aug 24;13:953439. doi: 10.3389/fimmu.2022.953439. eCollection 2022.
10
Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.腺苷脱氨酶 2 缺乏症(DADA2):固有免疫与适应性免疫的相互作用。
Front Immunol. 2022 Jul 11;13:935957. doi: 10.3389/fimmu.2022.935957. eCollection 2022.
Ann Rheum Dis. 2017 Feb;76(2):468-472. doi: 10.1136/annrheumdis-2016-209841. Epub 2016 Aug 26.
4
ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters.ADA2 缺陷症:两姐妹的新表型及新突变病例报告。
RMD Open. 2016 May 16;2(1):e000236. doi: 10.1136/rmdopen-2015-000236. eCollection 2016.
5
Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.腺苷脱氨酶 2 缺乏症:15 例表型和基因型描述。
Arthritis Rheumatol. 2016 Sep;68(9):2314-22. doi: 10.1002/art.39699.
6
Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.腺苷脱氨酶2缺乏导致抗体缺乏。
J Clin Immunol. 2016 Apr;36(3):179-86. doi: 10.1007/s10875-016-0245-x. Epub 2016 Feb 27.
7
Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.由于相同的纯合R169Q突变导致的ADA2缺乏症患者的表型变异性。
Rheumatology (Oxford). 2016 May;55(5):902-10. doi: 10.1093/rheumatology/kev439. Epub 2016 Feb 10.
8
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.IL-17RA 和腺苷脱氨酶 2 缺陷导致的复发性感染和慢性炎症:来自同胞的报告。
J Allergy Clin Immunol. 2016 Apr;137(4):1189-1196.e2. doi: 10.1016/j.jaci.2015.07.053. Epub 2015 Nov 20.
9
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.造血干细胞移植可挽救腺苷脱氨酶2缺乏症患者的免疫表型并预防血管病变。
J Allergy Clin Immunol. 2015 Jan;135(1):283-7.e5. doi: 10.1016/j.jaci.2014.10.010. Epub 2014 Nov 25.
10
Mutations in CECR1 associated with a neutrophil signature in peripheral blood.与外周血中性粒细胞特征相关的CECR1突变。
Pediatr Rheumatol Online J. 2014 Sep 24;12:44. doi: 10.1186/1546-0096-12-44. eCollection 2014.